These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 22245424)
1. FAM5C is a soluble osteoblast differentiation factor linking muscle to bone. Tanaka K; Matsumoto E; Higashimaki Y; Sugimoto T; Seino S; Kaji H Biochem Biophys Res Commun; 2012 Feb; 418(1):134-9. PubMed ID: 22245424 [TBL] [Abstract][Full Text] [Related]
2. Role of osteoglycin in the linkage between muscle and bone. Tanaka K; Matsumoto E; Higashimaki Y; Katagiri T; Sugimoto T; Seino S; Kaji H J Biol Chem; 2012 Apr; 287(15):11616-28. PubMed ID: 22351757 [TBL] [Abstract][Full Text] [Related]
3. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts. Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653 [TBL] [Abstract][Full Text] [Related]
4. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799 [TBL] [Abstract][Full Text] [Related]
5. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779 [TBL] [Abstract][Full Text] [Related]
6. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945 [TBL] [Abstract][Full Text] [Related]
7. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines. Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729 [TBL] [Abstract][Full Text] [Related]
8. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix. Okamura H; Yoshida K; Ochiai K; Haneji T Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816 [TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. Yuasa T; Kataoka H; Kinto N; Iwamoto M; Enomoto-Iwamoto M; Iemura S; Ueno N; Shibata Y; Kurosawa H; Yamaguchi A J Cell Physiol; 2002 Nov; 193(2):225-32. PubMed ID: 12385000 [TBL] [Abstract][Full Text] [Related]
10. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
11. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558 [TBL] [Abstract][Full Text] [Related]
12. Serpina3n, Dominantly Expressed in Female Osteoblasts, Suppresses the Phenotypes of Differentiated Osteoblasts in Mice. Ishida M; Kawao N; Okada K; Tatsumi K; Sakai K; Nishio K; Kaji H Endocrinology; 2018 Nov; 159(11):3775-3790. PubMed ID: 30304388 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945 [TBL] [Abstract][Full Text] [Related]
15. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro. Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328 [TBL] [Abstract][Full Text] [Related]
17. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation. Guo J; Cooper LF Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801 [TBL] [Abstract][Full Text] [Related]
19. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix. Lee CH; Huang YL; Liao JF; Chiou WF Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985 [TBL] [Abstract][Full Text] [Related]
20. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. Gutierrez J; Osses N; Brandan E J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]